Medasense offers a breakthrough technology that enables clinicians to optimize and personalize pain control and avoid overmedication. Founded by Galit Zuckerman in 2008, Medasense is backed by investors that include LGL Partners, Olive Tree Ventures, Baxter Ventures, Sabadell Venture Capital, and Ofakim Hi-Tech Ventures and is headquartered in Ramat Gan.